A vascular protective concept in hypertension and heart failure.
Bühler
F R
FR
F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Ball
S G
SG
Baumgartner
H R
HR
Ertem
G
G
Ferrannini
E
E
Goldstein
S
S
Karpov
Y A
YA
Kiowski
W
W
Widmann
T
T
Zanchetti
A
A
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D065128:Endothelin Receptor Antagonists; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D007333:Insulin Resistance / Q000502:physiology; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D065128:Endothelin Receptor Antagonists; D005343:Fibrinolytic Agents; D002784:Cholesterol